ARCHIVES

Are Cancer Drugs Getting Better? FDA’s Richard Pazdur Says “Yes”

This article is from The Cancer Letter archive.

Vol. 40 No. 07 | February 14, 2014

Download PDF Visit The Full Archive

Related Articles

Maggie’s Bill Pays Off; NCI Celebrates 40th

August 12, 1977

Patients Advocates Develop Statement On Health Care Reform

March 12, 1993

Phase III Trial Demonstrates Early Docetaxel Combined With ADT Can Extend Survival

December 27, 2013

Also in this 8-page issue: NCI advisors approve $15-million set-aside for laboratory testing on “reduced harm” tobacco products.

July 9, 2004

FDA News: Rule Limits Drug Pioneers To 30-Month Patent Extension

June 20, 2003

In Brief: Goldman Named Director, Albert Einstein Cancer Center; Wiernik Resumes Post

October 20, 1995